Harrow, Inc.
HROW
#6056
Rank
A$1.63 B
Marketcap
A$43.47
Share price
-1.61%
Change (1 day)
-16.79%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -A$13.89 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$33.19 Million, an increase over its 2024 earnings that were of A$7.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$13.89 Million-141.83%
2025 A$33.19 M317.34%
2024 A$7.95 M-329.09%
2023 -A$3.48 Million-224.34%
2022 A$2.79 M3.01%
2021 A$2.71 M149.06%
2020 A$1.08 M434.29%
2019 A$0.2 M-102.68%
2018 -A$7.6 Million-57.11%
2017 -A$17.71 Million-21.93%
2016 -A$22.68 Million5.11%
2015 -A$21.58 Million46.16%
2014 -A$14.76 Million32.68%
2013 -A$11.13 Million42.63%
2012 -A$7.8 Million
2010 -A$3.61 Million-45.76%
2009 -A$6.65 Million21.83%
2008 -A$5.46 Million-491.97%
2007 A$1.39 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 1,423.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.43 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA